Return to Today's science sparks archives

2019-02-01

Fig. 1 Clinical Pattern of Acquired Resistance.

Fig. 1 Clinical Pattern of Acquired Resistance.
  • Hu ZI, Hellmann MD, Wolchok JD, Vyas M, Shia J, Stadler ZK, Diaz LA Jr, O'Reilly EM

  • J Immunother Cancer. 2018 Nov 20;6(1):127.
Open Access button

2019-02-04

Fig. 1 Flow diagram of our general management strategies for patients with solid tumors with findings of clonal hematopoiesis (CH).

Fig. 1 Flow diagram of our general management strategies for patients with solid tumors with findings of clonal hematopoiesis (CH).
  • Bolton KL, Gillis NK, Coombs CC, Takahashi K, Zehir A, Bejar R, Garcia-Manero G, Futreal A, Jensen BC, Diaz LA Jr, Gupta D, Mantha S, Klimek V, Papaemmanuil E, Levine R, Padron E

  • J Clin Oncol. 2019 Jan 1;37(1):7-11.

2019-02-05

Fig. 2 Types of individualized local therapy for infants treated on Children's Oncology Group ARST0331 (low-risk protocol) and ARST0531 (intermediate-risk protocol).

Fig. 2 Types of individualized local therapy for infants treated on Children's Oncology Group ARST0331 (low-risk protocol) and ARST0531 (intermediate-risk protocol).
  • Bradley JA, Kayton ML, Chi YY, Hawkins DS, Tian J, Breneman J, Wolden SL, Walterhouse D, Rodeberg DA, Donaldson SS

  • Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):19-27.

2019-02-06

Fig. 1 Progressive changes in neocortical interneuron output of dividing NKX2.1+ MGE/PoA RGPs.

Fig. 1 Progressive changes in neocortical interneuron output of dividing NKX2.1+ MGE/PoA RGPs.
  • Sultan KT, Liu WA, Li ZL, Shen Z, Li Z, Zhang XJ, Dean O, Ma J, Shi SH

  • Nat Commun. 2018 Nov 2;9(1):4595.
Open Access button

2019-02-07

Fig. 1 miR-155-mediated Ago binding occurs at distinct sites in four immune cell types.

Fig. 1 miR-155-mediated Ago binding occurs at distinct sites in four immune cell types.
  • Hsin JP, Lu Y, Loeb GB, Leslie CS, Rudensky AY

  • Nat Immunol. 2018 Oct;19(10):1137-1145.

2019-02-08

Fig. 1 Core components of integrative oncology for evidence-informed patient-centered care: (A) three main therapeutic categories, and (B) components of evidence-informed practice.

Fig. 1 Core components of integrative oncology for evidence-informed patient-centered care: (A) three main therapeutic categories, and (B) components of evidence-informed practice.
  • Latte-Naor S, Mao JJ

  • J Oncol Pract. 2019 Jan;15(1):7-14.

2019-02-11

Fig. 1 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope.

Fig. 1 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope.
  • YĆ©lamos O, Braun RP, Liopyris K, Wolner ZJ, Kerl K, Gerami P, Marghoob AA

  • J Am Acad Dermatol. 2019 Feb;80(2):365-377.

2019-02-12

Fig. 1 Breast white adipose tissue inflammation by BMI category (n = 91).

Fig. 1 Breast white adipose tissue inflammation by BMI category (n = 91).
  • Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA, Hershman DL, Dannenberg AJ, Iyengar NM

  • Cancer Prev Res (Phila). 2019 Jan;12(1):21-30.

2019-02-13

Fig. 1 Vascular structures and fibrosis of basal cell carcinoma on dermoscopy.

Fig. 1 Vascular structures and fibrosis of basal cell carcinoma on dermoscopy.
  • Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM

  • J Am Acad Dermatol. 2019 Feb;80(2):321-339.

2019-02-14

Fig. 1 Cathepsin K-Cre labels periosteal mesenchymal cells.

Fig. 1 Cathepsin K-Cre labels periosteal mesenchymal cells.
  • Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, Li N, Liu Y, Yang YS, Eiseman M, Shim JH, Hameed M, Healey JH, Bostrom MP, Landau DA, Greenblatt MB

  • Nature. 2018 Oct;562(7725):133-139.

2019-02-18

Figure 1 WL12 binding interface on PD-L1 overlaps with PD-1 and PD-L1 therapeutics.

Figure 1 WL12 binding interface on PD-L1 overlaps with PD-1 and PD-L1 therapeutics.
  • Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S

  • J Clin Invest. 2019 Feb 1;129(2):616-630.
Open Access button